The company said, “While we remain confident in the long-term fundamentals in our portfolio, near-term results are being negatively affected by increased price sensitivity and continued macroeconomic volatility. We currently expect Q4 RevPAR growth to range from (2.0%)-(2.5%) as operating trends reflect sequential improvement from the second and third quarters of this year. We expect capital expenditures for FY25 of $60M-$65M on a pro rata basis.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INN:
